For the past 25 years, the public and private sectors have worked together to establish New York City as a global leader in life sciences research and innovation. Thanks to that coordinated effort, the city was able to respond to COVID-19 efficiently and effectively, becoming a model for other urban areas as COVID-19 cases peaked across the U.S.--and showcasing a burgeoning life sciences industry in the city that's poised for future growth.

Under the guidance of the New York City Economic Development Corporation (NYCEDC), life sciences companies came together to churn out personal protective equipment (PPE)--4.2 million gowns, 8.4 million face shields-- plus 1 million COVID test kits that were delivered to hospitals, clinics and community testing sites.

"It was a tangible example of how partnerships could help solve problems. We're going to see a lot more of that out of New York City," says Doug Thiede, senior vice president of life sciences and healthcare at NYCEDC.

Now it's time to look to the future of life sciences--and there's no better location than New York City. The city offers a diverse talent pool, premiere academic and medical institutions and a varied healthcare-delivery infrastructure that has encouraged life sciences stakeholders from around the world to establish and grow their presence here. And the city continues to make substantial investments to solidify its lead in meeting the needs of life sciences innovators.


Read the full story in Fierce Biotech